Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders

Details for Australian Patent Application No. 2006244245 (hide)

Owner Alcon, Inc.

Inventors Graff, Gustav; Brooks, Amy C.; Owen, Geoffrey Robert

Agent Spruson & Ferguson

Pub. Number AU-B-2006244245

PCT Pub. Number WO2006/121964

Priority 60/679,510 10.05.05 US

Filing date 8 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 18 November 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/542 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/121964 Priority application(s): WO2006/121964

18 November 2010 Application Accepted

  Published as AU-B-2006244245

17 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244254-Custom planter and method of custom planting

2006244244-Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders